Heron Therapeutics, Inc. · NASDAQ:HRTX
Hensley Mark Earl exercised options for 11,770 Heron Therapeutics, Inc. shares (Form 4)
Traded Apr 30, 2026 · Filed May 4, 2026
On Apr 30, 2026, Hensley Mark Earl (Chief Operating Officer) exercised options for 11,770 Heron Therapeutics, Inc. shares, leaving 11,770 shares. Filed May 4, 2026 (Form 4).
- Options exercised
- 11,770 shares
- Holding after
- 11,770 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | Option exercise | 11,770 | 11,770 | Direct |
Source
Related
- Heron Therapeutics, Inc.
- Hensley Mark Earl
- Heron Therapeutics, Inc. shareholders
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026
- Form 4 · Hensley Mark Earl · May 7, 2026
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Forbes William P · Aug 3, 2026
- Form 4 · Duarte Ira · Aug 3, 2026